» Articles » PMID: 32751401

The Pathogen Shows High Minimum Inhibitory Concentrations for Antimicrobials Commonly Used for Bovine Respiratory Disease

Overview
Specialty Pharmacology
Date 2020 Aug 6
PMID 32751401
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

is an overlooked pathogen often involved in bovine respiratory disease (BRD), which affects cattle around the world. BRD results in lost production and high treatment and prevention costs. Additionally, chronic therapies with multiple antimicrobials may lead to antimicrobial resistance. Data on antimicrobial susceptibility to is limited so minimum inhibitory concentrations (MIC) of a range of antimicrobials routinely used in BRD were evaluated using a broth microdilution technique for 41 isolates collected in Italy between 2011-2019. While all isolates had low MIC values for florfenicol (<1 μg/mL), many showed high MIC values for erythromycin (MIC90 ≥8 μg/mL). Tilmicosin MIC values were higher (MIC50 = 32 μg/mL) than those for tylosin (MIC50 = 0.25 μg/mL). Seven isolates had high MIC values for lincomycin, tilmicosin and tylosin (≥32 μg/mL). More, alarmingly, results showed more than half the strains had high MICs for enrofloxacin, a member of the fluoroquinolone class considered critically important in human health. A time-dependent progressive drift of enrofloxacin MICs towards high-concentration values was observed, indicative of an on-going selection process among the isolates.

Citing Articles

Dynamics of the nasopharyngeal microbiome of apparently healthy calves and those with clinical symptoms of bovine respiratory disease from disease diagnosis to recovery.

Centeno-Martinez R, Klopp R, Koziol J, Boerman J, Johnson T Front Vet Sci. 2023; 10:1297158.

PMID: 38033643 PMC: 10687565. DOI: 10.3389/fvets.2023.1297158.


Evaluating the potential of third generation metagenomic sequencing for the detection of BRD pathogens and genetic determinants of antimicrobial resistance in chronically ill feedlot cattle.

Freeman C, Herman E, Younes J, Ramsay D, Erikson N, Stothard P BMC Vet Res. 2022; 18(1):211.

PMID: 35655189 PMC: 9161498. DOI: 10.1186/s12917-022-03269-6.

References
1.
GOURLAY R, Leach R . A new mycoplasma species isolated from pneumonic lungs of calves (Mycoplasma dispar sp. nov.). J Med Microbiol. 1970; 3(1):111-23. DOI: 10.1099/00222615-3-1-111. View

2.
Friis N . Mycoplasma dispar as a causative agent in pneumonia of calves. Acta Vet Scand. 1980; 21(1):34-42. PMC: 8317724. View

3.
Lysnyansky I, Gerchman I, Mikula I, Gobbo F, Catania S, Levisohn S . Molecular characterization of acquired enrofloxacin resistance in Mycoplasma synoviae field isolates. Antimicrob Agents Chemother. 2013; 57(7):3072-7. PMC: 3697329. DOI: 10.1128/AAC.00203-13. View

4.
Portis E, Lindeman C, Johansen L, Stoltman G . A ten-year (2000-2009) study of antimicrobial susceptibility of bacteria that cause bovine respiratory disease complex--Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni--in the United States and Canada. J Vet Diagn Invest. 2012; 24(5):932-44. DOI: 10.1177/1040638712457559. View

5.
Francoz D, Fortin M, Fecteau G, Messier S . Determination of Mycoplasma bovis susceptibilities against six antimicrobial agents using the E test method. Vet Microbiol. 2004; 105(1):57-64. DOI: 10.1016/j.vetmic.2004.10.006. View